Navigation Links
ABX CROSSROADS Advances Discussion, Call to Action Regarding Antibiotic Resistance
Date:11/2/2015

NASHVILLE, Tenn., Nov. 2, 2015 /PRNewswire/ -- In response to the growing  number of international news stories about antibiotic resistance and bacterial superbugs, Diatherix Laboratories and Thermo Fisher Scientific will convene ABX CROSSROADS, a national symposium to explore the clinical, financial and operational challenges facing healthcare providers in the "post-antibiotic era."

ABX CROSSROADS will assemble a national audience of pharmacists, hospitalists, infection control specialists and healthcare administrators on Nov. 6, at the Hutton Hotel in Nashville. The day-long symposium is designed to help participants share knowledge, learn best practices and advance the national dialogue on antimicrobial stewardship.

"The alarming speed of the antibiotic resistance crisis is clearly outpacing conventional thinking," said Chris Linthwaite, president of genetic sciences at Thermo Fisher Scientific. "Only through a focused, national dialogue that is supported by innovative thinking and collaboration will we be able to explore new strategies to address this global threat to human health."

James Michael Keegan, M.D., Principal and Service Line Leader for Antibiotic Stewardship at Pershing Yoakley & Associates, will serve as moderator for ABX CROSSROADS, facilitating several industry thought leaders through a day long discussion:

Ed Septimus, M.D., FIDSA, FACP, FSHEA, Medical Director Infection Prevention and Epidemiology Clinical Services Group at HCA Healthcare System, will discuss the Crisis of Antimicrobial Resistance and deliver a call to action for healthcare providers worldwide.

Ronald Wyatt, M.D., M.H.A., Medical Director of Healthcare Improvement for The Joint Commission will discuss antibiotics and Patient Safety in the Context of Quality Improvement.

A discussion on Antimicrobial Stewardship in the Age of Pay for Performance and Patient Centered Care will be led by Keith S. Kaye, M.D., M.P.H., FIDSA, FACP, FSHEA, Medical Director of Hospital Epidemiology and Antimicrobial Stewardship Detroit Medical Center and Professor of Medicine at Wayne State University.

Kenneth P. Klinker, PharmD, Clinical Specialist in Infectious Diseases with University of Florida Shands Hospital, will provide financial and operational considerations in his discussion of Quantifying Antimicrobial Stewardship Results for the C-Suite.

Kavita K. Trivedi, M.D., principal and founder of Trivedi Consultants, LLC, will discuss Coordinating Patient Care Beyond the Acute Care Setting.

Senior Vice President of Physician Services and Clinical Integration for Catholic Health Initiatives T. Clifford Deveny, M.D., finishes the day discussing with a challenge for participants to become "Change Agents" of antimicrobial stewardship.

To register for ABX CROSSROADS, or to learn more about the event, visit www.ABXCROSSROADS.com.  Become part of the national dialogue on antibiotic resistance by following ABX CROSSROADS on Twitter, LinkedIn, YouTube or Vimeo.

Media Contact:
Leslie Raney
615-297-7766


'/>"/>
SOURCE ABX CROSSROADS
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Vaccines at the Crossroads: Outbreaks On the Rise Across America
2. ABX CROSSROADS to Convene National Dialogue on Antibiotic Resistance in Healthcare
3. Bio-Artificial Pancreas Technology to Cure Diabetes Advances
4. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
5. Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) -- Technology Trend Analysis -- By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis -- Estimates up to 2018
6. Rheumatology Network Presents Latest Advances Against Baffling Inflammatory Diseases From Major Rheumatology Conference
7. FIU Researcher Advances Retinal Implant That Could Restore Sight For The Blind
8. German Experts Present Medical Imaging Advances at RSNA 13
9. Ventilators Market to 2020 - Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
10. KemPharm, Inc. Advances KP201 Clinical Program with Initiation of Human Abuse Liability and Human Gastrointestinal Motility Trials
11. TB Alliance Advances Next-Generation TB Drug Candidate into Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2018)... ... August 03, 2018 , ... Flexefits, a pioneer in direct ... especially for its allowing participants in Direct Primary Care arrangements to keep HSA eligibility ... at $150 per individual and $300 per family per month.) , “We are very ...
(Date:8/3/2018)... ... , ... In order to improve safety for everyone throughout the summer, personal ... significant risks of injury that many amusement park rides present during the summer months. ... a thrilling ride on a roller coaster. Unfortunately, these fun times can quickly turn ...
(Date:8/2/2018)... ... 02, 2018 , ... What: The Wharton School is pleased to invite business ... up to five business reporters who cover aspects of public policy to attend the ... Each funding opportunity covers the cost of tuition, course materials, most group meals, lodging ...
Breaking Medicine Technology:
(Date:8/14/2018)... IRVINE, Calif. (PRWEB) , ... August 14, 2018 ... ... nation’s leading dental support organizations (DSO) with nearly 400 affiliated offices across 16 ... & Orthodontics in San Diego, California. , Smile Brands will provide full-service ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com recently awarded a five-star ... gout? This painful, persistent condition originates in the liver and is characterized by ... acid. Other contributing factors may be medication side effects, overweight, and unhealthy diet. ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of ... ruptured, according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), ... rates monitored by the FDA. As an MRI is recommended by FDA after ...
(Date:8/9/2018)... ... August 09, 2018 , ... RiverGlade Capital (“RiverGlade”), is ... and will have an exclusive relationship with the firm. As an Operating ... human capital sourcing, and deal origination, evaluation and diligence. He brings a ...
(Date:8/7/2018)... , ... August 07, 2018 , ... ... its line of Nancy’s Probiotic Foods. These rich, cream-on-top-style yogurts are made with ... grains, yielding milk that's high in omega-3 fatty acids. Nancy’s sources the milk ...
Breaking Medicine News(10 mins):